Medication-info.com Search Menu

Rykindo extended-release microspheres: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Boxed warning
Strength:
25 mg/2 mL, 37.5 mg/2 mL, 50 mg/2 mL
Other brand names:
Active ingredient:

Patient information: uses, side effects, how to take - Rykindo extended-release microspheres

INSTRUCTIONS FOR USE

RYKINDO® [ray-KIN-do]

(risperidone)

injection, for gluteal intramuscular use

This Instruction for Use contains information on how to inject RYKINDO®

Important Information You Need to Know Before Injecting RYKINDO®

  • For gluteal intramuscular injection use only

For gluteal intramuscular injection only. Do not inject by any other route. Alternate injections between the two buttocks.

  • Wait 30 minutes

Remove dose pack from the refrigerator and allow to sit at room temperature for at least 30 minutes prior to preparation. Do not warm any other way. Prepare medication when you are ready to administer the dose.

  • Use components provided

The components in this dose pack are specifically designed for use with RYKINDO. RYKINDO must be reconstituted only in the diluent supplied in the dose pack. Do not substitute ANY components of the dose pack.

  • Do not store suspension after reconstitution.

Administer dose as soon as possible after reconstitution to avoid settling.

  • Proper dosing

The entire contents of the vial must be administered to ensure the intended dose of RYKINDO is delivered.

  • Do not reuse.

RYKINDO® is for one-time use only. Do not reuse RYKINDO.

The components of the single-dose kit are shown in Figure 1.

Figure1: Single-dose Kit Components

Preparing to Inject RYKINDO®

Step 1. Take out kit and connect vial adapter to vial

Wait 30 minutes

Remove dose pack from the refrigerator and allow to sit at room temperature for at least 30 minutes before reconstituting.

Do not warm any other way.

Remove cap from vial

Flip off colored cap from vial.

Wipe top of the gray stopper with an alcohol swab. Allow to air dry.

Do not remove gray rubber stopper.

Prepare vial adapter

Hold sterile blister as shown. Peel back and remove paper backing.

Do not remove vial adapter from blister.

Do not touch spike tip at any time. This will result in contamination.

Connect vial adapter to vial

Place vial on a hard surface and hold by the base. Center vial adapter over the gray rubber stopper. Push vial adapter straight down onto vial top until it snaps securely into place.

Do not place vial adapter on at an angle or diluent may leak upon transfer to the vial.

Step 2. Connect prefilled syringe to vial adapter

Remove sterile blister

Keep vial vertical to prevent leakage. Hold base of vial and pull up on the sterile blister to remove.

Do not shake.

Do not touch exposed luer opening on vial adapter.

This will result in contamination.

Use proper grip

Hold by the LUER-LOK ADAPTER at the tip of the syringe.

Do not hold syringe by the glass barrel during assembly.

Remove cap

Holding the transparent LUER-LOK ADAPTER, unscrew the translucent gray cap.

Do not snap or cut off the translucent gray cap.

Do not touch syringe tip. This will result in contamination.

The unscrewed cap can be discarded.

Connect syringe to vial adapter

Hold vial adapter by skirt to keep stationary.

Hold syringe by the LUER-LOK ADAPTER then turn it to connect with the luer opening of the vial adapter.

Do not hold the glass syringe barrel. This may cause the LUER-LOK ADAPTER to loosen or detach.

Attach the syringe to the vial adapter with a firm clockwise twisting motion until it feels snug.

Do not over-tighten. Over-tightening may cause the syringe tip to break.

Step 3. Reconstitute powder

Inject diluent

Inject entire amount of diluent from syringe into the vial.

Suspend powder in diluent

Continuing to hold down the plunger rod, shake vigorously for at least 30 seconds, as shown.

Check the suspension. When properly mixed, the suspension appears uniform, thick and milky in color.

Immediately proceed to the next step so suspension does not settle.

Transfer suspension to syringe

Invert vial completely. Slowly pull plunger rod down to withdraw entire contents from the vial into the syringe.

Remove vial adapter

Hold the LUER-LOK ADAPTER on the syringe and unscrew from vial adapter.

Tear section of the vial label at the perforation. Apply detached label to the syringe for identification purposes.

Discard both vial and vial adapter appropriately.

Step 4. Attach needle

Take out needle

Take out needle for gluteal injection.

Attach needle

Peel blister pouch open part way and use to grasp the base of the needle, as shown.

Holding the LUER-LOK ADAPTER on the syringe, attach syringe to needle luer connection with a firm clockwise twisting motion until snug.

Do not touch needle luer opening. This will result in contamination.

Resuspend powder

Fully remove the blister pouch.

Just before injection, shake syringe vigorously for 20 to 30 seconds until there is no deposition of powder, as some settling will have occurred.

Step 5. Inject RYKINDO®

Remove transparent needle protector

Move the needle safety device back towards the syringe, as shown. Then hold the LUER-LOK ADAPTER on syringe and carefully pull the transparent needle protector straight off.

Do not twist transparent needle protector, as the luer connection may loosen.

Remove air bubbles

Hold syringe upright and tap gently to make any air bubbles rise to the top.

Slowly and carefully press plunger rod upward to remove air.

Inject

Immediately inject entire contents of syringe intramuscularly into the upper outer quadrant of the gluteal muscle of the patient. Do not administer by any other route.

Secure needle in safety device

Using one hand, place needle safety device at a 45-degree angle on a hard, flat surface. Press down with a firm, quick motion until needle is fully engaged in safety device.

Avoid needle stick injury:

Do not use two hands.

Do not intentionally disengage or mishandle the needle safety device.

Do not attempt to straighten the needle or engage the safety device if the needle is bent or damaged.

Properly dispose of syringes

Check to confirm needle safety device is fully engaged.

Discard in an approved sharps container.

Storing RYKINDO®

Store kit in refrigerator at 2° to 8°C (36° to 46°F). Protect from light.

If refrigeration is unavailable, RYKINDO can be stored in its unopened original packaging at temperatures not exceeding 77°F (25°C) for no more than 7 days prior to administration. After removal from the refrigerator, use RYKINDO within 7 days or discard.

For product or service related questions, call 1-800-548-9765 or visit www.rykindo.com.

Shandong Luye Pharmaceutical Co., Ltd.

No.15 Chuangye Road, High-tech Zone,

Yantai, Shandong, 264003

China

This Instruction for Use has been approved by the U.S. Food and Drug Administration.

Issued: 05/2023

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 212849 · View the label on DailyMed

Revision date stated in the text: May 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Rykindo extended-release microspheres

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Atypical Antipsychotic
Active ingredient Risperidone
Dosage form Kit
Marketing status listed in the FDA NDC Directory
Company (applicant) SHANDONG LUYE
FDA approval NDA 212849New Drug Application (NDA) Approved January 13, 2023
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
25 mg/2 mL – 1 in 1 kit NDC 72526-102-11
37.5 mg/2 mL – 1 in 1 kit NDC 72526-103-11
50 mg/2 mL – 1 in 1 kit NDC 72526-104-11

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.